PDF) WTX101 in patients newly diagnosed with Wilson disease: final
Por um escritor misterioso
Descrição
Copper depletion modulates mitochondrial oxidative phosphorylation to impair triple negative breast cancer metastasis
Recent advances in Wilson disease - Moini - Translational Gastroenterology and Hepatology
Bis-choline tetrathiomolybdate in patients with Wilson's disease: an open-label, multicentre, phase 2 study - The Lancet Gastroenterology & Hepatology
Biochemical Markers for the Diagnosis and Monitoring of Wilson Disease. - Abstract - Europe PMC
Practical insights into chronic management of hepatic Wilson's disease
Biochemical Markers for the Diagnosis and Monitoring of Wilson Disease. - Abstract - Europe PMC
Bis-choline tetrathiomolybdate in patients with Wilson's disease: an open-label, multicentre, phase 2 study - The Lancet Gastroenterology & Hepatology
PDF) Wilson's Disease: Clinical Practice Guidelines of the Indian National Association for Study of the Liver, the Indian Society of Pediatric Gastroenterology, Hepatology and Nutrition, and the Movement Disorders Society of India
Missing heritability of Wilson disease: a search for the uncharacterized mutations
PDF) WTX101 in patients newly diagnosed with Wilson disease: final results of a global, prospective phase 2 trial
Aftab ALA, Professor, MBBS MD PhD FRCP, University of Surrey, Guildford, School of Biosciences and Medicine & Department of Health Management and Strategy
Copper(I)-binding properties of de-coppering drugs for the treatment of Wilson disease. α-Lipoic acid as a potential anti-copper agent
de
por adulto (o preço varia de acordo com o tamanho do grupo)
